This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the prevention and management of chemotherapy-induced alopecia (CIA). Therefore, we hypothesize that PBMT can reduce the severity of CIA in gynecological and breast cancer patients, increasing the patient's QoL.
Diagnosed with gynecological cancer (endometrium, cervix, ovarian or vulva) or breast cancer
Receiving chemotherapy ((Carbo)-Taxol)
Age ≥ 18 years
Able to comply to the study protocol
Metastatic disease
Pregnancy
Active infection of the scalp
Previous diagnosis of a hair loss condition